Background. Nociceptin/orphanin FQ (N/OFQ) is the endogenous agonist of the orphan opioid receptor-like receptor (NOP receptor, previously termed ORL1), a novel member of the opioid receptor family. The aim of the present study, using in vitro newborn rat preparations, was to elucidate the roles N/OFQ and the NOP receptor play in medullary generation of respiratory rhythm.
Accepted for publication: April 8, 2003 In addition to the three classical opioid receptors (m, d, and k) a new member of the opioid receptor family, nociceptin/ orphanin FQ (N/OFQ) peptide (NOP) receptor (previously termed ORL1 receptor), was cloned in 1994. 1 2 Although structurally related to other members of the opioid receptor family, this receptor was found to bind to classical m-, d-, and k-opioid ligands with very low af®nity. In 1995, N/OFQ was isolated and identi®ed as the endogenous ligand for the NOP receptor. 3 4 NOP receptor and N/OFQ are involved in many physiological functions. 5 Whilst abundance of the NOP receptor in the medulla oblongata has been noted, 6 7 the roles of the NOP receptor and N/OFQ speci®cally in the respiratory centre of the medulla oblongata have not yet been described.
In vitro brainstem-spinal cord preparation from newborn rat has been introduced as an in vitro model for the study of the mammalian respiratory centre. 8 Cumulative evidence has shown that this model is well suited to the analysis of primary respiratory rhythm generation and modulation. direct effects of neuroactive substances and drugs on the structures that generate basal respiratory rhythm can be observed. In addition, this environment precludes the in¯uence of peripheral chemosensors and suprabulbar structures.
The aim of the present study was, using the above model, to elucidate the roles of N/OFQ and the NOP receptor in respiratory rhythm generation in the medulla oblongata.
Methods
This study was approved by the Animal Care Committee of the Hokkaido University Graduate School of Medicine. The head and upper thorax of Wistar rats (3 days old, n=48) were dissected under deep ether anaesthesia, and the brainstem and spinal cord were isolated. The brainstem was rostrally decerebrated between the VIth cranial nerve roots and the lower border of the trapezoid body. The preparation was placed in a small chamber (volume 2.5 ml) and continuously perfused at a rate of 5.0±6.0 ml min ±1 with arti®cial cerebrospinal¯uid (aCSF) (mM): NaCl, 124; KCl, 5.0; KH 2 PO 4 , 1.2; CaCl 2 , 2.4; MgSO 4 , 1.3; NaHCO 3 , 26; glucose, 30. The solution was equilibrated with oxygen 95% and carbon dioxide 5% to pH 7.4 at 27.5°C. The reservoir containing the aCSF, the perfusion system, and the recording chamber was heated using a water bath to 27.5 (SD 0.3)°C. The pH and temperature of the aCSF in the reservoir, and the temperature of the superfusate in the recording chamber, were continuously monitored.
Respiratory activity corresponding to inspiration was monitored at the C4 or C5 ventral root using suction electrodes; this activity is known to synchronize with phrenic nerve discharges and with contraction of the inspiratory intercostal muscles. 8 10 Recording signals were ampli®ed and band-pass ®ltered (50 Hz to 3 kHz; Fig. 1 ).
More than 20 min after the recording of respiratory activity was established, drugs were administered through the recording chamber via the perfusion system. N/OFQ 10 nM, 30 nM, or 100 nM was applied for 20 min with each preparation being exposed once to a single concentration of N/OFQ. In the ®ve preparations used as non-treated controls, no drug was applied. Naloxone 1 mM, the putative 
Discussion
The current study demonstrated that N/OFQ has an inhibitory effect on the medullary structures involved in N/OFQ and the respiratory centre the generation of respiratory rhythm via activation of the NOP receptor, a new member of the opioid receptor family. Since N/OFQ was discovered in 1995, many studies have been performed to elucidate its actions on in vivo activity when injected intracerebroventricularly or microinjected into restricted areas of the central nervous system, of animals including rats and mice. Those studies showed that N/OFQ has many physiological and pharmacological actions in vivo, including nociception; analgesia; effects on locomotion, learning, cardiovascular control and inhibition of cough. 3 4 11±14 However, there has been no report of respiratory effects of N/OFQ. This discrepancy between the results of the present in vitro study and those of previous in vivo studies suggests that the effects of N/OFQ on suprabulbar structures may modify medullary NOP receptor-mediated respiratory depressant effect.
CompB is reported to be a potent and selective NOP receptor antagonist. 15 The results of the current series of experiments using CompB show that N/OFQ in the medullary structures is able to modulate respiratory rhythm and this effect is mediated by NOP receptors. The present study also showed that CompB had no effect on fR generation per se indicating that endogenous N/OFQ does not participate in basal respiratory rhythm generation in the medulla oblongata. [Phe 1 y(CH 2 -NH)Gly 2 ]-N/OFQ (1±13)-NH 2 was introduced as a competitive antagonist of the NOP receptor in guinea-pig ileum and mouse vas deferens preparations. 16 However, other studies have shown that this peptide acts as an agonist or a partial agonist for the NOP receptor in vitro and in vivo, 17±19 although the reason for the differences in its pharmacodynamic pro®le is unclear. The diversity of this agent's actions on the NOP receptor limits its utility as a pharmacological tool for manipulating the NOP receptor. The present study showed that [Phe 1 y(CH 2 -NH)Gly 2 ]-N/OFQ (1±13)-NH 2 acted mainly as an agonist for the NOP receptor. In the present study, pretreatment with naloxone did not affect the N/OFQ-induced fR reduction, whereas ®ndings in our previous study showed that naloxone can completely reverse the fR reduction produced by m-, d-, and k-opioid receptor agonists in this preparation. 20 These ®ndings indicate that conventional opioid receptors are not involved in the action of N/OFQ in the medullary respiration-related structures.
The present study indicated that the ventral portion of the medulla oblongata is important in N/OFQ-induced fR reduction, given that removal of the dorsal half of the medulla did not cause any changes in the response to N/OFQ application. Previous studies have suggested that the centre or kernel of respiratory rhythm generation may be located in the pre-Bo Ètzinger complex, a limited region of the rostroventrolateral medulla that corresponds to the nucleus reticularis rostroventrolateralis.
10 21 22 The mechanism of respiratory rhythmogenesis is not yet fully understood. Studies using in situ hybridization and immunohistochemistry show high NOP mRNA expression and moderate to high density of NOP receptors in the respiratory-related regions of the rostral ventrolateral medulla. 6 7 These ®ndings suggest that N/OFQ-induced fR reduction observed here may result from activation of these NOP receptors.
We conclude that N/OFQ acts as a neuromodulator to reduce respiratory frequency in the respiratory rhythmgeneration centre of the medulla oblongata, and that this action of N/OFQ is mediated by NOP receptors in the ventral portion of this structure. 
